Biostar Pharmaceuticals, Inc. BSPM
Set alert
At close · Oct 29
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 263
- Vol
- 150
- Avg vol
- 61
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- 0.00
- Beta
- 3.14
- Short ratio
- 3.00
- Inst. own
- 1.43%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.03
- 200-d avg
- 1.88
- 1y target
- 7.00
Key statistics
- Market cap
- 1.37M
- Enterprise value
- 3.78M
- Trailing P/E
- 1.53
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 4.32
- Price / book
- 0.04
- EPS (TTM)
- 0.34
- Beta
- 3.14
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 294.01%
- Revenue (TTM)
- 317.79K
- Revenue growth
- 0.00%
- Free cash flow
- 7.47M
- Total cash
- 364.97K
- Total debt
- 2.43M
- Return on equity
- 2.66%
- Shares outstanding
- 2.64M
- Short % of float
- 0.00%
- 50-day average
- 1.03
- 200-day average
- 1.88
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 20, 2017 | Sep 1, 2017 | 0.00 | -0.05 | — | — |
| Nov 15, 2017 | Jun 1, 2017 | 0.00 | -0.50 | — | — |
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Major
- Country
- China
- Website
- biostarpharmaceuticals.com
News
Your note
Sign in to keep a note on BSPM — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Acadian Asset Management | 4.06% | 107,196 | 227.25K | Jun 29, 2018 |
| Barclays PLC | 0.69% | 18,300 | 38.80K | Jun 29, 2018 |
| Morgan Stanley | 0.15% | 3,950 | 8.37K | Jun 29, 2018 |
| Deutsche Bank Aktiengesellschaft | 0.13% | 3,501 | 7.42K | Jun 29, 2018 |
| Ifp Advisors, Inc | 0.12% | 3,250 | 6.89K | Jun 29, 2018 |
| UBS Group AG | 0.01% | 297 | 629 | Jun 29, 2018 |